{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075995","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.426422+00:00","generated_at":"2026-06-01T00:26:29.599746+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BrainStorm Cell Therapeutics raises $4.0M in registered direct offering and warrants","bullets":["Gross proceeds ~$4.0M from sale of 11.1M shares or pre-funded warrants at $0.36/share.","Private placement of warrants to buy 16.7M shares at $0.3912, exercisable after 6 months, 5-year term.","Existing warrants for 4.05M shares amended: exercise price cut to $0.3912, expiry extended to 2029.","Offering expected June 28, 2024; Maxim Group as placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075995","json":"https://secwatch.observer/filing/0001104659-24-075995.json","markdown":"https://secwatch.observer/filing/0001104659-24-075995.md","text":"https://secwatch.observer/filing/0001104659-24-075995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924075995/0001104659-24-075995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924075995/tm2418388d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:26:29.599746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}